America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
Stephany Kirkpatrick's Orum pushes for financial inclusivity with fast, reliable payments, aiming to end financial barriers for underserved communities.